Post by
goldennorth on Jun 29, 2021 4:34pm
Real Possibilities And Great Potential.
Experence and very industry knowledable managment. Management’s personal relationships with business owners and executives throughout the industry allows the Company to get access to decision makers and potential targets quickly and effectively.
Salona’s strategy is to acquire companies, paying private company multiples, predominantly through earn-outs heavy in stock. Earn out structures help to keep float tight and allow the company to ensure cash flow and revenue is earned in advance of payment.
SGMD has a deep and full pipeline of potential acquisition targets – all medical device companies with between $5M - $20M in revenues w/ cash flow.
This stock has excellent fundamentals and great price momentum. by Thomson Reuters Stock Reports. It's going to continue to move up and could easly be trading at $2.00 or more by the mid July. It's a good buy.
https://2e0c9480-053d-40d5-b81e-656a8b3c8346.filesusr.com/ugd/3c6412_6b173990300d4e32bb53252bee95fd55.pdf
Comment by
lscfa on Jun 30, 2021 11:43am
My bet is they do an equity raise before they do an acquistion. Stock price is overvalued.
Comment by
constructionsite on Jun 30, 2021 11:56am
No, that seems quite unlikely, at this point. They have already been very clear about their plans for funding their acquisitions, and have set aside 15-18 million shares (described in their various NRs) earmarked for potential acquisitions (they are aiming at COs between $5m and $20m in sales).